Assessment of a New Ginsenoside Rh2 Nanoniosomal Formulation for Enhanced Antitumor Efficacy on Prostate Cancer: An in vitro Study

Assessment of a New Ginsenoside Rh2 Nanoniosomal Formulation for Enhanced Antitumor Efficacy on Prostate Cancer: An in vitro Study

Hadi Zare-Zardini,1– 3 Ashraf Alemi,4 Asghar Taheri-Kafrani,5 Seyed Ahmad Hosseini,6 Hossein Soltaninejad,7,8 Amir Ali Hamidieh,9 Mojtaba Haghi Karamallah,10 Majid Farrokhifar,11 Mohammad Farrokhifar12 1Hematology and Oncology Research Center, Shahid Sadoughi University of Medical Sciences...

Full description

Bibliographic Details
Main Authors: Zare-Zardini H, Alemi A, Taheri-Kafrani A, Hosseini SA, Soltaninejad H, Hamidieh AA, Haghi Karamallah M, Farrokhifar M
Format: Article
Language:English
Published: Dove Medical Press 2020-08-01
Series:Drug Design, Development and Therapy
Subjects:
nanoniosomal
ginsenoside rh2
chemotherapy
pc3 prostate cancer cell line
Online Access:https://www.dovepress.com/assessment-of-a-new-ginsenoside-rh2-nanoniosomal-formulation-for-enhan-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/assessment-of-a-new-ginsenoside-rh2-nanoniosomal-formulation-for-enhan-peer-reviewed-article-DDDT

Similar Items